Bayer AG's Stivarga (regorafenib) Tablets Approved in Europe

Bayer HealthCare and Onyx Pharmaceuticals, Inc. announced today that the European Commission has approved StivargaA tablets for the treatment of adult patients with metastatic colorectal cancer .

http://www.biospace.com/news_story.aspx?StoryID=307184&full=1